Operating
Change in AP
Kailera Therapeutics Change in AP decreased by 176.7% to -$495.00K in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
An increase is generally positive for cash flow, as it allows the company to retain cash longer, provided it does not damage supplier relationships.
Detailed definition
This measures the change in the amount the company owes to its suppliers and vendors for goods and services received. An...
Peer comparison
Standard metric; companies often aim to optimize payment terms to maximize cash availability.
Metric ID:
change_in_accounts_payableHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $645.00K | -$495.00K |
| QoQ Change | — | -176.7% |
| YoY Change | — | -176.7% |
Range-$495.00K – $645.00K
Avg YoY Growth-176.7%
Median YoY Growth-176.7%
Change in AP at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's change in ap?
- Kailera Therapeutics (KLRA) reported change in ap of -$495.00K in Q1 2026.
- What does change in ap mean?
- The change in money the company owes to its suppliers.